相关实验视频
Updated: Jul 26, 2025
13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.7K
在预测慢性阻塞性肺部疾病恶化风险时,稳定状态下的血中乙氨基酸细胞数量的变化
Wang Chun Kwok1, Chi Hung Chau2, Terence Chi Chun Tam1
1Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China.
概括
血中乙氨基酸细胞数量的变化可以预测慢性阻塞性肺病 (COPD) 的恶化. 以50细胞/μL为氨基酸变异的门,可以识别患有更高风险的患者,特别是那些基线氨基酸水平较低的患者.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 临床免疫学临床免疫学
背景情况:
- 稳定的血中乙氨基酸水平对慢性阻塞性肺病 (COPD) 恶化的风险有预后影响.
- 使用单个乙氨基酸细胞数值值来预测临床结果是具有挑战性的.
- 稳定状态期间血中乙酸细胞数量的变化可能为恶化风险提供额外的预测信息.
研究的目的:
- 为了研究血中乙氨基酸细胞数量的变化在预测COPD恶化风险在一年内所起的作用.
- 为了确定氨基酸细胞数量的变化是否提供了超出稳定状态水平的额外预后价值.
- 为了确定在预测恶化的过程中对乙氨基变异性的潜在切断值.
主要方法:
- 对275名中国COPD患者进行了回顾性队列研究.
- 分析稳定状态血中乙氨基酸细胞计数,包括最小值和最大值.
- 统计分析,以评估乙酸细胞变异性和恶化风险之间的关联,包括调整的几率比率和ROC分析.
主要成果:
- 氨基酸基线计数的更高变化与COPD恶化风险的增加有关.
- 观察到调整后的几率比为1.001 (p=0.050) 对于每单位的乙氨基酸变异性增加.
- 50个细胞/μL的截止值变化显示了82.9%的灵敏度和79.3%的特异性来预测恶化 (AUC=0.862).
结论:
- 根据基线氨酸细胞计数的变化可以预测COPD恶化风险.
- 这种预测值在基线乙氨基酸细胞计数低于300细胞/μL的患者中显得最为显著.
- 建议在大规模前性研究中进一步验证.
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:22Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.9K
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K